These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


252 related items for PubMed ID: 18480510

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Lifestyle and other related factors for the development of mixed connective tissue disease among Japanese females in comparison with systemic lupus erythematosus.
    Washio M, Fujii T, Kuwana M, Kawaguchi Y, Mimori A, Horiuchi T, Tada Y, Takahashi H, Mimori T, Japan MCTD study group.
    Mod Rheumatol; 2014 Sep; 24(5):788-92. PubMed ID: 24499377
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Is MCTD a distinct entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients.
    De Clerck LS, Meijers KA, Cats A.
    Clin Rheumatol; 1989 Mar; 8(1):29-36. PubMed ID: 2743718
    [Abstract] [Full Text] [Related]

  • 27. Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases.
    Katayama Y, Kohriyama K.
    J Rheumatol; 2001 Feb; 28(2):288-91. PubMed ID: 11246663
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Undifferentiated systemic connective tissue disease-"overlap' in Zimbabwe.
    Lutalo SK, Glavintcheva I.
    Cent Afr J Med; 1996 Jun; 42(6):166-9. PubMed ID: 8870313
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Development of "mixed connective tissue disease" (MCTD) from discoid lupus erythematosus].
    Bauer R, Schultz-Ehrenburg U, Orfanos CE.
    Hautarzt; 1981 Jan; 32(1):23-7. PubMed ID: 6971860
    [Abstract] [Full Text] [Related]

  • 35. Immune pathogenesis of Mixed Connective Tissue Disease: a short analytical review.
    Hoffman RW, Maldonado ME.
    Clin Immunol; 2008 Jul; 128(1):8-17. PubMed ID: 18439877
    [Abstract] [Full Text] [Related]

  • 36. Pulmonary vascular manifestations of mixed connective tissue disease.
    Bull TM, Fagan KA, Badesch DB.
    Rheum Dis Clin North Am; 2005 Aug; 31(3):451-64, vi. PubMed ID: 16084318
    [Abstract] [Full Text] [Related]

  • 37. Trends in deaths from systemic lupus erythematosus--United States, 1979-1998.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2002 May 03; 51(17):371-4. PubMed ID: 12018384
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.